2m 2m 2m 2m 2m 2m 2m
PEPGEN (PEPG)
NASDAQ
$3.06+$0.08 (+2.68%)
Price as of Sep 11, 2026 7:30 PM EDT- $206.4MMarket Cap
- 101.35%1-Year Change
- BiotechnologyIndustry
PEPGEN (PEPG)
$3.06+$0.08 (+2.68%)
PEPG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.98 | ||
Change | -$0.04 (-1.32%) | ||
Open | $3.03 | ||
High | $3.10 | ||
Low | $2.95 | ||
Previous Close | $3.02 | ||
Volume | 683,010 | ||
30-Day Average Volume | 752,755 | ||
1-Week Change | -4.18% | ||
1-Month Change | 2.76% | ||
1-Year Change | 101.35% | ||
3-Year Change | -51.47% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 69.3M | ||
Total Assets | $141.4M | ||
Market Cap | $206.4M | ||
Enterprise Value | $183.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$15.8M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.5M | ||
Net Working Capital | $111.3M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -11 | ||
PEG | N/A | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue